Table 1.
ASH | NASH | ||
---|---|---|---|
Age, year, mean (SD) | 58 (7.2) | 69 (5.1) | p<0.0001 |
M:F | 18:1 | 16:8 | p=0.055 |
# tumors | 3.1 (SD 1.9) | 2.5 (SD 2.0) | p=0.36 |
Tumor size, cm mean (SD) | 1.7 (SD 1.0) | 2.0 (SD 1.5) | p=0.13 |
Tumor differentiation (per tumor nodule) | p=0.12 | ||
Well | 12 (27%) | 8 (16%) | |
Moderate | 31 (70%) | 35 (71%) | |
Poor | 1 (3%) | 6 (12%) | |
Microscopic vascular invasion | 10/19 (53%) | 16/24 (67%) | p=0.53 |
Macroscopic vascular invasion | 1/19 (5%) | 1/24 (4%) | p=1 |
AFP > 9 | 10/18 (56%) | 9/22 (41%) | p=0.53 |
SH-HCC | 14/19 (74%) | 17/24 (71%) | p=1 |
Predominant SH-HCC | 9/19 (47%) | 12/24 (50%) | p=1 |
Glycogenated hepatocyte nuclei | 7/19 (37%) | 15/24 (63%) | p=0.13 |